174 related articles for article (PubMed ID: 16788383)
1. Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.
Barker DF; Husain A; Neale JR; Martini BD; Zhang X; Doll MA; States JC; Hein DW
Pharmacogenet Genomics; 2006 Jul; 16(7):515-25. PubMed ID: 16788383
[TBL] [Abstract][Full Text] [Related]
2. Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1).
Husain A; Barker DF; States JC; Doll MA; Hein DW
Pharmacogenetics; 2004 Jul; 14(7):397-406. PubMed ID: 15226672
[TBL] [Abstract][Full Text] [Related]
3. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts.
Boukouvala S; Sim E
Basic Clin Pharmacol Toxicol; 2005 May; 96(5):343-51. PubMed ID: 15853926
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements.
Husain A; Zhang X; Doll MA; States JC; Barker DF; Hein DW
Drug Metab Dispos; 2007 Sep; 35(9):1649-56. PubMed ID: 17591675
[TBL] [Abstract][Full Text] [Related]
6. Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues.
Husain A; Zhang X; Doll MA; States JC; Barker DF; Hein DW
Drug Metab Dispos; 2007 May; 35(5):721-7. PubMed ID: 17287389
[TBL] [Abstract][Full Text] [Related]
7. Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1).
Butcher NJ; Arulpragasam A; Pope C; Minchin RF
Biochem J; 2003 Dec; 376(Pt 2):441-8. PubMed ID: 12946272
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct.
Millner LM; Doll MA; Stepp MW; States JC; Hein DW
Carcinogenesis; 2012 Feb; 33(2):348-55. PubMed ID: 22114069
[TBL] [Abstract][Full Text] [Related]
9. NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.
Millner LM; Doll MA; Cai J; States JC; Hein DW
Mol Carcinog; 2012 Aug; 51(8):636-46. PubMed ID: 21837760
[TBL] [Abstract][Full Text] [Related]
10. The divergent 5' termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure.
Elwood PC; Nachmanoff K; Saikawa Y; Page ST; Pacheco P; Roberts S; Chung KN
Biochemistry; 1997 Feb; 36(6):1467-78. PubMed ID: 9063895
[TBL] [Abstract][Full Text] [Related]
11. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.
Butcher NJ; Tetlow NL; Cheung C; Broadhurst GM; Minchin RF
Cancer Res; 2007 Jan; 67(1):85-92. PubMed ID: 17210686
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1.
Butcher NJ; Minchin RF
Carcinogenesis; 2010 May; 31(5):820-6. PubMed ID: 20176657
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions.
Zhu Y; States JC; Wang Y; Hein DW
Birth Defects Res A Clin Mol Teratol; 2011 Feb; 91(2):77-84. PubMed ID: 21290563
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter.
Bonamassa B; Ma Y; Liu D
AAPS J; 2012 Sep; 14(3):581-90. PubMed ID: 22644701
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer.
Kim SJ; Kang HS; Chang HL; Jung YC; Sim HB; Lee KS; Ro J; Lee ES
Oncol Rep; 2008 Mar; 19(3):663-8. PubMed ID: 18288399
[TBL] [Abstract][Full Text] [Related]
16. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
[TBL] [Abstract][Full Text] [Related]
17. Primary acute lymphoblastic leukemia cells use a novel promoter and 5'noncoding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start.
Flatley RM; Payton SG; Taub JW; Matherly LH
Clin Cancer Res; 2004 Aug; 10(15):5111-22. PubMed ID: 15297414
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
[TBL] [Abstract][Full Text] [Related]
19. Regulation of parathyroid hormone-related peptide (PTHrP) gene transcription: cell- and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements.
Campos RV; Wang C; Drucker DJ
Mol Endocrinol; 1992 Oct; 6(10):1642-52. PubMed ID: 1280327
[TBL] [Abstract][Full Text] [Related]
20. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene.
Walsh NC; Cahill M; Carninci P; Kawai J; Okazaki Y; Hayashizaki Y; Hume DA; Cassady AI
Gene; 2003 Mar; 307():111-23. PubMed ID: 12706893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
